15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Xpeng Inc, 5 rate it Buy or better, 0 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $15.00 to $29.40, a moderate spread. The average target of $22.88 sits 79% above the current $12.79. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.22 next quarter toward $3.05 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Moderate Buy
Strong Buy00%
Buy583%
Hold00%
Sell117%
Strong Sell00%
Based on 6 analysts giving stock ratings to Xpeng Inc.
As of Jul, 5 of 6 firms rate XPEV a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
XPEV EPS & revenue forecast
EPS · NEXT QUARTER
$-0.22
Range $-0.33 – $-0.11 · 2 analysts · +38% YoY
Next period, 2 analysts expect Xpeng Inc to earn $-0.22 a share (range $-0.33 – $-0.11), versus $-0.16 a year earlier. Full-year consensus is $-2.15, growing to $3.05 the year after.
REVENUE · NEXT QUARTER
$26.1B
Range $24.9B – $27.7B · 2 analysts · +28% YoY
Revenue is expected to reach $26.1B (range $24.9B – $27.7B), +28.1% year-over-year. Full-year consensus is $92.2B, rising to $117.1B next year.
Top analysts covering Xpeng Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on XPEV.
#1
Jiong Shao
Barclays · Rank #43
Sell
$15.00+17.3% to target
Overall win rate
51%
+ Follow
#2
EH
Eugene Hsiao
Macquarie
Buy
$19.00+48.6% to target
Coverage
—
+ Follow
#3
JC
Jeff Chung
Citigroup
Buy
$22.50+75.9% to target
Coverage
—
+ Follow
#4
NL
Nick Lai
JP Morgan
Buy
$30.00+134.6% to target
Coverage
—
+ Follow
#5
MH
Ming Hsun Lee
B of A Securities
Buy
$25.00+95.5% to target
Coverage
—
+ Follow
XPEV stock forecast FAQ
What is XPEV's average 12-month price target?+
The 5 analysts with a live target average $22.88 for Xpeng Inc over the next 12 months, ranging from a $29.40 high to a $15.00 low.
Is XPEV stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 6 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for XPEV?+
The Street-high target is $29.40 (Citigroup), and the Street-low is $15.00 (Barclays). The average of all 5 active targets is $22.88.
How many Wall Street analysts cover XPEV?+
6 analysts have an active rating on Xpeng Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering XPEV?+
Among analysts who currently cover XPEV, Jiong Shao of Barclays has the strongest overall Quantellect track record (Rank #43). Their current call is Sell with a $15.00 target.
What is Xpeng Inc's projected EPS for next quarter?+
The consensus estimate is $-0.22 per share (range $-0.33 – $-0.11) across 2 analysts. Full-year EPS is projected at $-2.15, rising to $3.05 the following year.
How much revenue is Xpeng Inc expected to report next quarter?+
Consensus revenue is $26.1B (range $24.9B – $27.7B). Full-year revenue is projected at $92.2B, growing to $117.1B next year.
Have analysts been upgrading or downgrading XPEV lately?+
As of Jul, 5 of 6 firms rate XPEV a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XPEV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
